Skip to main content
. 2017 May 19;8(39):65171–65185. doi: 10.18632/oncotarget.18015

Table 6. Univariate and multivariate analysis in patients with lower ESCC.

Variable  Median survival (months) Univariate analysis Multivariate analysis
HR 95% CI P value HR 95% CI P value
Sex 0.598 0.310-1.154 0.125
 Male 17
 Female 26
Age 1.553 0.934-2.582 0.09
 ≥70 17
 <70 16
T stage 1.060 0.705-1.594 0.778
 T1-2 27
 T3 14
 T4 17
N stage 2.479 1.742-3.529 < 0.001*** 2.106 1.447-3.064 < 0.001***
 N1 33
 N2 19
 N3 9
TNM stage 5.241 2.108-13.03 < 0.001*** 4.814 1.792-12.928 0.002**
 II
 III 18
 IV 7
Supraclavicular nodes 1.102 0.679-1.787 0.695
 Positive 13
 Negative 19
Left gastric nodes 1.052 0.648-1.710 0.837
 Positive 16
 Negative 17
Celiac nodes 0.347 0.206-0.584 < 0.001*** 0.574 0.292-1.128 0.107
 Positive 11
 Negative 21
Common hepatic nodes 0.264 0.136-0.513 < 0.001*** 0.377 0.160-0.890 0.026*
 Positive 11
 Negative 19
Treatment modality 1.502 0.893-2.526 0.126
 Chemoradiotherapy 17
 Radiotherapy alone 17
Radiation dose 1.415 0.877-2.284 0.155
 ≥60 Gy 17
 <60 Gy 14

*, P < 0.05; **, P < 0.01; ***, P < 0.001.